Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Sevoflurane
The First People's Hospital of Lianyungang
Aged
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Anesthesia, General
1 trial -
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Sodium Bicarbonate Ringer's Solution
The First People's Hospital of Lianyungang
Hyperlactacidemia
1 trial -
Study Agent
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Surgery-radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
T cell injection targeting CD7 chimeric antigen receptor
The First People's Hospital of Lianyungang
T-ALL
1 trial -
TRF (Tocotrienol-rich-fraction)
United Therapeutics Europe Ltd
End Stage Renal Disease
1 trial -
Targeted Amino Acid Supplement
United Therapeutics Europe Ltd
Parkinson Disease (PD)
1 trial -
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
Topical diclofenac sodium gel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hand Osteoarthritis
1 trial -
Transesophageal echocardiography
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Critically Ill
1 trial -
Tumor Specific Antigen-loaded Dendritic Cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tumor Gastric
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Vaginal progesterone
Hospital Authority, Hong Kong
Preterm Birth
1 trial -
Village doctor-led tailored health management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
Virtual Reality (VR) Contrast Function Test
Apellis Europe B.V.
Age-Related Macular Degeneration
1 trial -
Vitamin C
The First People's Hospital of Lianyungang
Ageing
1 trial -
WonderLab Collagen Tripeptide Drink
Chongqing Precision Biotech Co., Ltd
Skin Laxity
1 trial -
Yishen Qutong Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Esophageal Squamous Cell Carcinoma (ESCC)
1 trial -
anti-thymocyte globulin
Ultragenyx UK Limited
Immunologic Deficiency Syndromes
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources